Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Pharmaceutical approval update.
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.
Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report.
Outcome measures in multiple sclerosis.
[LINGO-1 Expression of brain tissue in Experimental Autoimmune Encephalomyelitis Mouse].
Adaptive personalized training games for individual and collaborative rehabilitation of people with multiple sclerosis.
Neurological disorders and inflammatory bowel diseases.
Emergent properties of microglia.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Treating prolactinoma can prevent autoimmune diseases.
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
Rotation-invariant multi-contrast non-local means for MS lesion segmentation.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
Pages
« first
‹ previous
…
545
546
547
548
549
550
551
552
553
…
next ›
last »